Axsome Thera (NQ: AXSM )

67.10 USD UNCHANGED

Streaming Delayed Price Updated: 4:54 PM EDT, Oct 28, 2020 Add to My Watchlist

Price and Volume

Volume	0
Open	67.10
Bid (Size)	65.00 (1)
Ask (Size)	74.40 (1)
Prev. Close	67.10
Today's Range	67.10 - 67.10
52wk Range	20.48 - 109.94
Shares Outstanding	25,685,492
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Axsome Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020

October 28, 2020

Axsome Therapeutics Announces $225 Million Term Loan Facility with Hercules Capital

September 29, 2020

Performance

YTD	-33.77%	-33.77%
1 Month	-12.24%	-12.24%
3 Month	-9.65%	-9.65%
6 Month	-32.01%	-32.01%
1 Year	+182.05%	+182.05%

More News

Axsome Therapeutics Presents New Data from MOMENTUM Phase 3 Trial with AXS-07 Demonstrating Rapid Onset of Action and Reduced Symptom Recurrence in the Acute Treatment of Migraine

September 24, 2020

Axsome Therapeutics Announces Expedited Development of AXS-12 for the Treatment of Narcolepsy Based on FDA Breakthrough Therapy Meeting

September 21, 2020

Axsome Therapeutics Announces AXS-07 Phase 3 Migraine Trial Results Selected by the American Academy of Neurology Science Committee as Featured Presentation

September 17, 2020

Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder

September 14, 2020

Axsome Therapeutics is Now Oversold (AXSM)

October 28, 2020

Axsome Therapeutics to Present New Data for AXS-05 in Major Depressive Disorder at the 33rd European College of Neuropsychopharmacology Congress

September 10, 2020

Notable Monday Option Activity: XPO, AXSM, MGNI

October 05, 2020

Analysts Forecast 15% Upside For The Holdings of ESML

October 05, 2020

Axsome Therapeutics Larger Than S&P 500 Component Under Armour

September 29, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.